Big Pharma Split Corp Class A (PRM) — Strategic Asset Allocation Index
Big Pharma Split Corp Class A (PRM) has a Strategic Asset Allocation Index of 166.3% as of December 2025. Strategic assets (PP&E of CA$- plus long-term investments of CA$30.38 Million) total CA$30.38 Million, measured against net assets of CA$18.27 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PRM net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Big Pharma Split Corp Class A Strategic Asset Allocation Index (2017–2025)
This chart shows how Big Pharma Split Corp Class A's Strategic Asset Allocation Index has evolved across 8 annual periods from 2017 to 2025. As of December 2025, the index stands at 166.3%, representing strategic assets of CA$30.38 Million against net assets of CA$18.27 Million CAD. For live market cap and overall valuation, see market value of Big Pharma Split Corp Class A.
Annual Strategic Asset Allocation Index for Big Pharma Split Corp Class A (2017–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Big Pharma Split Corp Class A from 2017 to 2025, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Big Pharma Split Corp Class A for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 166.3% | CA$30.38 Million | CA$- | CA$30.38 Million | CA$18.27 Million | ▼ -17.7 pp |
| 2024 | 184.0% | CA$25.17 Million | CA$- | CA$25.17 Million | CA$13.68 Million | ▲ +18.4 pp |
| 2023 | 165.6% | CA$26.25 Million | CA$- | CA$26.25 Million | CA$15.85 Million | ▲ +42.6 pp |
| 2022 | 123.0% | CA$24.27 Million | CA$- | CA$24.27 Million | CA$19.73 Million | ▼ -38.2 pp |
| 2021 | 161.3% | CA$36.13 Million | CA$- | CA$36.13 Million | CA$22.40 Million | ▼ -9.0 pp |
| 2020 | 170.2% | CA$22.45 Million | CA$- | CA$22.45 Million | CA$13.19 Million | ▼ -5.7 pp |
| 2018 | 175.9% | CA$33.14 Million | CA$- | CA$33.14 Million | CA$18.84 Million | ▲ +11.9 pp |
| 2017 | 164.0% | CA$30.63 Million | CA$- | CA$30.63 Million | CA$18.68 Million | — |